abstract |
A solid supplement comprising the following components (A) and (B): (A) sphingomyelin in an amount of 0.15 to 7 mass%; and (B) phosphatidyl inositol or a salt thereof. In the solid supplement, the ratio of the content of phosphatidyl inositol or the salt thereof (B) in terms of phosphatidyl inositol content to the content of sphingomyelin (A), i.e., [(B)/(A)], is 0.05 to 3 by mass. |